Boxes including AstraZeneca vaccine come to Soekarno-Hatta Airport in Tangerang, Banten, on March 8,2021 Indonesia gets 1.1 million doses of vaccine through Covax in this very first shipment.
BY: MARIA FATIMA BONA
MARCH 19, 2021
Jakarta. The Indonesian Health Ministry will start dispersing Covid-19 vaccine developed by UK pharmaceutical company AstraZeneca on Monday after it was put on a hold-up amid reports of embolism in Europe.
The World Health Company and the European Medicines Company (EMA) have stated there was no proof of a link between the vaccine and the reported embolism.
Health Ministry spokesperson Siti Nadia Tarmizi said the vaccine will be distributed across the nation after the Drug and Food Supervisory Company (BPOM) raised the suspension on Friday.
” As the implementer of the nationwide vaccination drive, we will start dispersing AstraZeneca vaccine throughout Indonesia on Monday,” Siti stated in a video conference in Jakarta.
She expressed self-confidence that all 1.1 million dosages of AstraZeneca vaccine in stock will be administered prior to they expire in late May.
” We are currently able to administer as much as 250,000 doses of vaccine each day,” she stated.
Speaking separately, BPOM spokeswoman Lucia Rizka Andalusia said the agency has consulted with the WHO and health authorities in other nations about the security of AstraZeneca vaccine, following reports of embolism after they vaccine was administered.
She indicated EMA’s conclusion on Thursday that “the benefits of the vaccine in combating the still prevalent danger of Covid-19 continue to exceed the danger of negative effects”.
The EMA also specified that AstraZeneca vaccine is not related to an increase in the total danger of embolism in those who get it.
” The EMA also underlines that there is no quality concern related to specific batches of AstraZeneca vaccine,” she stated.
Lucia said Indonesia received AstraZeneca vaccine manufactured in South Korea through multilateral plan Covax.
AstraZeneca is the second Covid-19 vaccine to be used in Indonesia, which has actually administered more than 7 million dosages of vaccine established by China’s Sinovac Biotech as of Friday.
More than 2 million Indonesian citizens have been totally immunized against Covid-19 and nearly 5 million have gotten at least a single dosage of Sinovac vaccine considering that the project started on January 13.
SHARE
